BioMarin Pharmaceutical Inc.
GB ˙ LSE ˙ US09061G1013
57,62 $ ↑1,19 (2,11%)
2026-06-05
DEL PRIS
SecurityGB:0HNC / BioMarin Pharmaceutical Inc.
InstitutionFred Alger Management, Llc
Latest Disclosed Ownership3,690 shares
Latest Disclosed Value $ 208,448
Fred Alger Management, Llc reports 33.57% decrease in ownership of 0HNC / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Fred Alger Management, Llc filed a 13F-HR form disclosing ownership of 3,690 shares of BioMarin Pharmaceutical Inc. (GB:0HNC) valued at $205,533 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 5,555 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -33.57% during the quarter. The current value of the position is $212,618 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BioMarin Pharmaceutical Equity 09061G101 3,690 -1,865 -33.57 208 -36.97 0.0006
2026-02-17 2025-12-31 13F BioMarin Pharmaceutical Equity 09061G101 5,555 -18,145 -76.56 330 -74.28 0.0013
2025-11-14 2025-09-30 13F BioMarin Pharmaceutical Equity 09061G101 23,700 -4,907 -17.15 1,284 -18.38 0.0050
2025-08-14 2025-06-30 13F BioMarin Pharmaceutical Equity 09061G101 28,607 -196 -0.68 1,573 -22.79 0.0070
2025-05-16 2025-03-31 13F BioMarin Pharmaceutical Equity 09061G101 28,803 2,933 11.34 2,036 19.76 0.0116
2025-02-14 2024-12-31 13F BioMarin Pharmaceutical Equity 09061G101 25,870 -703 -2.65 1,700 -8.94 0.0081
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 26,573 -2,943 -9.97 1,868 -23.17 0.0091
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 29,516 -1,664 -5.34 2,430 -10.76 0.0118
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 31,180 -2,209 -6.62 2,723 -15.41 0.0135
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 33,389 -7,493 -18.33 3,219 -11.00 0.0174
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 40,882 -6,715 -14.11 3,617 -12.32 0.0192
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 40,882 3,617
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 47,597 -85,326 -64.19 4,126 -68.09 0.0211
2023-05-16 2023-03-31 13F/A-1 BIOMARIN PHARMACEUTICALS Common 09061G101 132,923 60,297 83.02 12,925 71.97 0.0691
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 132,923 60,297 12,925 0.0641
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 72,626 33,940 87.73 7,516 129.22 0.0407
2022-11-15 2022-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 38,686 -32,718 -45.82 3,279 -44.58 0.0166
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 71,404 -51,391 -41.85 5,917 -37.51 0.0276
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 122,795 -93,055 -43.11 9,468 -50.35 0.0302
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 215,850 174,998 428.37 19,070 504.05 0.0478
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 40,852 2,701 7.08 3,157 -0.82 0.0075
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 38,151 7,711 25.33 3,183 38.45 0.0075
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 30,440 -415,970 -93.18 2,299 -94.13 0.0060
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 446,410 66,567 17.52 39,146 35.46 0.1018
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 379,843 -853,768 -69.21 28,898 -81.01 0.0839
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,233,611 1,215,604 6,750.73 152,154 9,896.98 0.5013
2020-05-19 2020-03-31 13F/A-1 BIOMARIN PHARMACEUTICALS Common 09061G101 18,007 6,937 62.66 1,522 62.61 0.0067
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 18,007 6,937 1,522 6,696.4275
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 11,070 4,314 63.85 936 105.71 0.0034
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 6,756 -13,247 -66.23 455 -73.44 0.0018
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 20,003 3,553 21.60 1,713 17.25 0.0066
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 16,450 -672,286 -97.61 1,461 -97.51 0.0058
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 688,736 -164,677 -19.30 58,646 -29.13 0.2700
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 853,413 -121,060 -12.42 82,755 -9.85 0.3107
2018-07-19 2018-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 974,473 39,852 4.26 91,795 21.15 0.3854
2018-05-10 2018-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 934,621 -89,411 -8.73 75,770 -17.02 0.3523
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,024,032 3,793 0.37 91,313 -3.83 0.4122
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,020,239 -8,790 -0.85 94,954 1.60 0.4441
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,029,029 -84,226 -7.57 93,456 -4.37 0.4464
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,113,255 28,122 2.59 97,722 8.71 0.4864
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,085,133 -559,696 -34.03 89,892 -40.93 0.4891
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,644,829 209,042 14.56 152,180 36.23 0.7812
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,435,787 196,503 15.86 111,705 9.28 0.5898
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 1,239,284 860,439 227.12 102,217 157.56 0.5177
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 378,845 -260,586 -40.75 39,687 -41.07 0.1930
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 639,431 -219,973 -25.60 67,345 -42.71 0.3675
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 859,404 289,873 50.90 117,549 65.62 0.5290
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 569,531 493,871 652.75 70,975 937.65 0.3197
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 75,660 7,125 10.40 6,840 38.32 0.0329
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 68,535 -36,274 -34.61 4,945 -24.16 0.0240
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 104,809 -109,175 -51.02 6,520 -55.33 0.0321
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 213,984 -56,075 -20.76 14,596 -23.17 0.0723
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICALS Common 09061G101 270,059 161,642 149.09 18,999 142.83 0.0968
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 108,417 73,179 207.67 7,824 298.37 0.0435
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICALS Common 09061G101 35,238 35,238 1,964 0.0117
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.